Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation.
| Image |  |
|---|---|
| Description | scientific article published on 08 August 2011 |
| Author/s |
author: Michael P Boyle Ronald C. Rubenstein |
| Publication date | August 8, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |